e-learning
resources
Vienna 2009
Monday, 14.09.2009
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function in patients with bronchiectasis is preserved by periodical treatment with antibiotics
F. C. Trudzinski, T. Kramm, M. Ulrich, A. Gröschel, G. W. Sybrecht (Homburg/Saar, Germany)
Source:
Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session:
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type:
Thematic Poster Session
Number:
2358
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. C. Trudzinski, T. Kramm, M. Ulrich, A. Gröschel, G. W. Sybrecht (Homburg/Saar, Germany). Lung function in patients with bronchiectasis is preserved by periodical treatment with antibiotics. Eur Respir J 2009; 34: Suppl. 53, 2358
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Periodical therapy with antibiotics preserves lung function in patients with bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
Lung function decline in patients with bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Lung function in patients cured for pulmonary tuberculosis
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Lung function defects in treated pulmonary tuberculosis patients
Source: Eur Respir J 2016; 47: 351-352
Year: 2016
Lung function defects in treated pulmonary tuberculosis patients
Source: Eur Respir J 2016; 47: 352-353
Year: 2016
Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002
Lung function at patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002
Short-term effect of autogenic drainage on ventilation inhomogeneity in adults with stable non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient
Year: 2016
Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Source: Eur Respir J 2016; 47: 651-654
Year: 2016
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Lung compliance in patients with pulmonary fibrosis with normal lung volumes
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept